Get started
Author

Cecilia Copparoni

Observed name: C. Copparoni
OpenAlex ID: A5020384120
High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients
2020 · Luca Cantini, Federica Pecci, et al. · European Journal of Cancer · 117
Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer
2021 · Alessandro Bittoni, Federica Pecci, et al. · Annals of Translational Medicine · 42
PDF
Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis
2020 · Luca Cantini, Federica Pecci, et al. · Lung Cancer · 18
Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab
2021 · Riccardo Giampieri, Alessio Lupi, et al. · Frontiers in Oncology · 13
BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma
2021 · Albero Murrone, Luca Cantini, et al. · Journal of Thoracic Disease · 10
PDF
Impact of Polypharmacy for Chronic Ailments in Colon Cancer Patients: A Review Focused on Drug Repurposing
2020 · Riccardo Giampieri, Luca Cantini, et al. · Cancers · 8
PDF
Statin treatment improves response to anti-PD1 agents in patients with malignant pleural mesothelioma and non-small cell lung cancer.
2020 · Luca Cantini, Federica Pecci, et al. · Journal of Clinical Oncology · 5
Hemoglobin and Neutrophil Count as Prognostic Factors in Cholangiocarcinoma Patients in 2nd Line Treatment Setting: Results from a Small Monocentric Retrospective Study
2023 · Carolina Liguori, Cecilia Copparoni, et al. · Current Oncology · 3
PDF
Prospective observational study of taste assay in patients with solid tumors treated with standard chemotherapy (POTATO)
2020 · Riccardo Giampieri, Elisa Pelati, et al. · Supportive Care in Cancer · 3
P-27 Retrospective observational analysis of p53 mutational status as a prognostic factor in TAS-102 treated metastatic colorectal cancer patients
2020 · R. Giampieri, A. Zizzi, et al. · Annals of Oncology · 2
PDF
P-117 Prognostic role of plasmatic exosomal and tissue caveolin-1 in metastatic pancreatic cancer patients
2020 · A. Bittoni, F. Pecci, et al. · Annals of Oncology · 2
Prospective nutritional status and body mass composition assessment in patients with advanced NSCLC treated with immune checkpoint inhibitors.
2024 · Federica Pecci, Valeria Cognigni, et al. · Journal of Clinical Oncology · 1
PDF
P-131 External validation of prognostic ALAN score in patients with inoperable bile duct cancer treated with second-line chemotherapy
2021 · R. Giampieri, C. Liguori, et al. · Annals of Oncology · 1
Cutaneous metastasis of rhabdomyosarcoma
2016 · M. Meneses, C. Copparoni, et al. · Journal of the European Academy of Dermatology and Venereology · 1
Double heterozygous pathogenic germline APC and MSH2 variants in a 16-year-old female diagnosed with colorectal cancer
2026 · Elena Maccaroni, Riccardo Bacalini, et al. · Familial Cancer
PDF
Oncological Genetic Counseling in Hereditary Breast and Ovarian Cancers and Lynch Syndrome High‐Risk Subjects: Evaluation of Efficacy and Outcomes Using the Genomics Outcome Scale
2026 · Elena Maccaroni, Rebecca Chiariotti, et al. · Human Mutation
Elucidating the role of baseline and on-treatment nutritional status and body composition on clinical outcomes in advanced nsclc patients treated with immunotherapy
2024 · G. Mentrasti, S. Lunetti, et al. · Clinical Nutrition ESPEN
1065P Prospective assessment of nutritional status in patients with advanced non-small cell lung cancer and renal cell carcinoma treated with immune checkpoint inhibitors
2023 · F. Pecci, G. Mentrasti, et al. · Annals of Oncology
PDF
Phase Angle Research Study in NeoplastIc Patients Treated with Standard Chemotherapy (PARSNIP)
2022 · Arianna Vignini, Cecilia Copparoni, et al. · Research Square
PDF
1905P BAP1 and miR-31 combination predicts outcome in epithelioid malignant pleural mesothelioma
2020 · F. Pecci, L. Cantini, et al. · Annals of Oncology
PDF
1902P Association of high-intensity statins with clinical outcome in malignant pleural mesothelioma and advanced non-small cell lung cancer patients treated with PD1 inhibitors
2020 · L. Cantini, F. Pecci, et al. · Annals of Oncology
P-75 Retrospective comparison between FLOT perioperative chemotherapy vs surgery followed by adjuvant chemotherapy: Results from a multicenter analysis
2020 · M. Baleani, A. Bittoni, et al. · Annals of Oncology
PDF
Works count: 22
Citation count: 226
H-index: 6
I10-index: 5
Year
Topic
Type